Intrahost modeling of artemisinin resistance in Plasmodium falciparum.
Artemisinin-resistant Plasmodium falciparum malaria has emerged in western Cambodia. Resistance is characterized by prolonged in vivo parasite clearance times (PCTs) following artesunate treatment. The biological basis is unclear. The hypothesis that delayed parasite clearance results from a stage-s...
| Autors principals: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Idioma: | English |
| Publicat: |
2011
|
| _version_ | 1826294987551145984 |
|---|---|
| author | Saralamba, S Pan-Ngum, W Maude, R Lee, S Tarning, J Lindegårdh, N Chotivanich, K Nosten, F Day, N Socheat, D White, N Dondorp, A White, L |
| author_facet | Saralamba, S Pan-Ngum, W Maude, R Lee, S Tarning, J Lindegårdh, N Chotivanich, K Nosten, F Day, N Socheat, D White, N Dondorp, A White, L |
| author_sort | Saralamba, S |
| collection | OXFORD |
| description | Artemisinin-resistant Plasmodium falciparum malaria has emerged in western Cambodia. Resistance is characterized by prolonged in vivo parasite clearance times (PCTs) following artesunate treatment. The biological basis is unclear. The hypothesis that delayed parasite clearance results from a stage-specific reduction in artemisinin sensitivity of the circulating young asexual parasite ring stages was examined. A mathematical model was developed, describing the intrahost parasite stage-specific pharmacokinetic-pharmacodynamic relationships. Model parameters were estimated using detailed pharmacokinetic and parasite clearance data from 39 patients with uncomplicated falciparum malaria treated with artesunate from Pailin (western Cambodia) where artemisinin resistance was evident and 40 patients from Wang Pha (northwestern Thailand) where efficacy was preserved. The mathematical model reproduced the observed parasite clearance for each patient with an accurate goodness of fit (rmsd: 0.03-0.67 in log(10) scale). The parameter sets that provided the best fits with the observed in vivo data consist of a highly conserved concentration-effect relationship for the trophozoite and schizont parasite stages, but a variable relationship for the ring stages. The model-derived assessment suggests that the efficacy of artesunate on ring stage parasites is reduced significantly in Pailin. This result supports the hypothesis that artemisinin resistance mainly reflects reduced ring-stage susceptibility and predicts that doubling the frequency of dosing will accelerate clearance of artemisinin-resistant parasites. |
| first_indexed | 2024-03-07T03:54:10Z |
| format | Journal article |
| id | oxford-uuid:c2488ae2-a929-44f3-9c5d-1d2fe625b158 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:54:10Z |
| publishDate | 2011 |
| record_format | dspace |
| spelling | oxford-uuid:c2488ae2-a929-44f3-9c5d-1d2fe625b1582022-03-27T06:07:53ZIntrahost modeling of artemisinin resistance in Plasmodium falciparum.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c2488ae2-a929-44f3-9c5d-1d2fe625b158EnglishSymplectic Elements at Oxford2011Saralamba, SPan-Ngum, WMaude, RLee, STarning, JLindegårdh, NChotivanich, KNosten, FDay, NSocheat, DWhite, NDondorp, AWhite, LArtemisinin-resistant Plasmodium falciparum malaria has emerged in western Cambodia. Resistance is characterized by prolonged in vivo parasite clearance times (PCTs) following artesunate treatment. The biological basis is unclear. The hypothesis that delayed parasite clearance results from a stage-specific reduction in artemisinin sensitivity of the circulating young asexual parasite ring stages was examined. A mathematical model was developed, describing the intrahost parasite stage-specific pharmacokinetic-pharmacodynamic relationships. Model parameters were estimated using detailed pharmacokinetic and parasite clearance data from 39 patients with uncomplicated falciparum malaria treated with artesunate from Pailin (western Cambodia) where artemisinin resistance was evident and 40 patients from Wang Pha (northwestern Thailand) where efficacy was preserved. The mathematical model reproduced the observed parasite clearance for each patient with an accurate goodness of fit (rmsd: 0.03-0.67 in log(10) scale). The parameter sets that provided the best fits with the observed in vivo data consist of a highly conserved concentration-effect relationship for the trophozoite and schizont parasite stages, but a variable relationship for the ring stages. The model-derived assessment suggests that the efficacy of artesunate on ring stage parasites is reduced significantly in Pailin. This result supports the hypothesis that artemisinin resistance mainly reflects reduced ring-stage susceptibility and predicts that doubling the frequency of dosing will accelerate clearance of artemisinin-resistant parasites. |
| spellingShingle | Saralamba, S Pan-Ngum, W Maude, R Lee, S Tarning, J Lindegårdh, N Chotivanich, K Nosten, F Day, N Socheat, D White, N Dondorp, A White, L Intrahost modeling of artemisinin resistance in Plasmodium falciparum. |
| title | Intrahost modeling of artemisinin resistance in Plasmodium falciparum. |
| title_full | Intrahost modeling of artemisinin resistance in Plasmodium falciparum. |
| title_fullStr | Intrahost modeling of artemisinin resistance in Plasmodium falciparum. |
| title_full_unstemmed | Intrahost modeling of artemisinin resistance in Plasmodium falciparum. |
| title_short | Intrahost modeling of artemisinin resistance in Plasmodium falciparum. |
| title_sort | intrahost modeling of artemisinin resistance in plasmodium falciparum |
| work_keys_str_mv | AT saralambas intrahostmodelingofartemisininresistanceinplasmodiumfalciparum AT panngumw intrahostmodelingofartemisininresistanceinplasmodiumfalciparum AT mauder intrahostmodelingofartemisininresistanceinplasmodiumfalciparum AT lees intrahostmodelingofartemisininresistanceinplasmodiumfalciparum AT tarningj intrahostmodelingofartemisininresistanceinplasmodiumfalciparum AT lindegardhn intrahostmodelingofartemisininresistanceinplasmodiumfalciparum AT chotivanichk intrahostmodelingofartemisininresistanceinplasmodiumfalciparum AT nostenf intrahostmodelingofartemisininresistanceinplasmodiumfalciparum AT dayn intrahostmodelingofartemisininresistanceinplasmodiumfalciparum AT socheatd intrahostmodelingofartemisininresistanceinplasmodiumfalciparum AT whiten intrahostmodelingofartemisininresistanceinplasmodiumfalciparum AT dondorpa intrahostmodelingofartemisininresistanceinplasmodiumfalciparum AT whitel intrahostmodelingofartemisininresistanceinplasmodiumfalciparum |